Correlation Between Pliant Therapeutics and Revolution Medicines
Can any of the company-specific risk be diversified away by investing in both Pliant Therapeutics and Revolution Medicines at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pliant Therapeutics and Revolution Medicines into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pliant Therapeutics and Revolution Medicines, you can compare the effects of market volatilities on Pliant Therapeutics and Revolution Medicines and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pliant Therapeutics with a short position of Revolution Medicines. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pliant Therapeutics and Revolution Medicines.
Diversification Opportunities for Pliant Therapeutics and Revolution Medicines
0.48 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Pliant and Revolution is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding Pliant Therapeutics and Revolution Medicines in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Revolution Medicines and Pliant Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pliant Therapeutics are associated (or correlated) with Revolution Medicines. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Revolution Medicines has no effect on the direction of Pliant Therapeutics i.e., Pliant Therapeutics and Revolution Medicines go up and down completely randomly.
Pair Corralation between Pliant Therapeutics and Revolution Medicines
Given the investment horizon of 90 days Pliant Therapeutics is expected to under-perform the Revolution Medicines. In addition to that, Pliant Therapeutics is 1.16 times more volatile than Revolution Medicines. It trades about -0.14 of its total potential returns per unit of risk. Revolution Medicines is currently generating about 0.33 per unit of volatility. If you would invest 4,775 in Revolution Medicines on August 27, 2024 and sell it today you would earn a total of 900.00 from holding Revolution Medicines or generate 18.85% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Pliant Therapeutics vs. Revolution Medicines
Performance |
Timeline |
Pliant Therapeutics |
Revolution Medicines |
Pliant Therapeutics and Revolution Medicines Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Pliant Therapeutics and Revolution Medicines
The main advantage of trading using opposite Pliant Therapeutics and Revolution Medicines positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pliant Therapeutics position performs unexpectedly, Revolution Medicines can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Revolution Medicines will offset losses from the drop in Revolution Medicines' long position.Pliant Therapeutics vs. Eliem Therapeutics | Pliant Therapeutics vs. HCW Biologics | Pliant Therapeutics vs. Scpharmaceuticals | Pliant Therapeutics vs. Milestone Pharmaceuticals |
Revolution Medicines vs. Blueprint Medicines Corp | Revolution Medicines vs. Sana Biotechnology | Revolution Medicines vs. Kymera Therapeutics | Revolution Medicines vs. Monte Rosa Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Stocks Directory Find actively traded stocks across global markets | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |